Shield Therapeutics, Xtract Resources and Alan Green

Mar 05, 12:55 PM

On the Vox Markets Podcast Today: 5th March 2019

Carl Sterritt, CEO and Founder of Shield Therapeutics #STX explains the significance of the lastest positive results received on its lead product, Feraccru®.

Colin Bird, Executive Chairman of Xtract Resources #XTR talks about the option agreement they've entered into for the copper-gold Eureka project in Zambia.

(Interview starts at 6 minutes 22 seconds)

Alan Green CEO of Brand Communications talks about: Cadence #KDNC AudioBoom #BOOM Europa Metals #EUZ

(Interview starts at 16 minutes 28 seconds)

Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast